Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
Original Report
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Glass House Analysis
Housing sits at the intersection of economic policy and the American Dream. For most families, their home represents their largest asset and their primary path to building generational wealth. When housing becomes unaffordable, the social fabric frays—young people delay family formation, workers can't relocate for better jobs, and communities lose the stability that comes from homeownership.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Trump says Kennedy Center will stay closed without renovation unless his name is added back
The ruling comes four months after the same judge ordered that the Kennedy Center could not be renamed to include President Trump's name.
Stocks drop as 10-year Treasury yield hits 19-year high, crude oil tops $106 a barrel: Live updates
The major averages closed lower on Monday as higher bond yields and oil prices kept the market under pressure.
Will Be 'Extremely Difficult' For The FOMC To Not Raise Rates Says Richards
Bond traders are pricing in a Federal Reserve interest-rate hike Wednesday with a level of conviction that has proven right for decades. Interest-rate swaps tied to Fed meeting dates show traders see...
Big Pharma Needs New Drugs. China Has Them
Big Pharma is betting on China for its next blockbuster drugs — what that shift means for patients and the future of US biotech dominance. (Source: Bloomberg)